Finless Foods is a technology company.
Finless Foods has raised $88.0M across 4 funding rounds.
Finless Foods has raised $88.0M in total across 4 funding rounds.
Finless Foods has raised $88.0M in total across 4 funding rounds.
Finless Foods's investors include 500 Global, Alkeon Capital, At One Ventures, BoxOne Ventures, Buckley Ventures, Matt Ocko, Earl Grey Capital, Endeavor Venture Funds, FirstHand Alliance, Goat Capital, Graph Ventures, GRID EXPONENTIAL.
# High-Level Overview
Finless Foods is a biotechnology company developing cell-cultured seafood alternatives, primarily focused on cultivated bluefin tuna.[2] The company uses cellular agriculture technology to grow marine-animal cells into fish products without traditional fishing or aquaculture, addressing both environmental sustainability and food security concerns.[5] Founded by molecular biologists Mike Selden and Brian Wyrwas, Finless Foods has raised approximately $54 million in funding and operates with 11-50 employees.[3] The company's mission centers on creating a future where ocean ecosystems thrive while providing consumers access to delicious, healthy seafood alternatives at competitive prices.[4]
Finless Foods serves the broader food industry and retail sectors by offering both plant-based and cell-cultured seafood solutions.[1] The company targets consumers and food service providers seeking sustainable protein options without the environmental devastation associated with wild-caught or farmed fish.[5] By positioning itself at the intersection of biotechnology and food production, Finless Foods addresses the depletion of wild fish populations—particularly bluefin tuna—while reducing the ecological impact of traditional aquaculture.
# Origin Story
Finless Foods was founded in June 2016 by Mike Selden and Brian Wyrwas, two molecular biologists in their mid-20s who met at the University of Massachusetts Amherst.[2] The co-founders began by researching the world's fastest-depleting fish populations, ultimately focusing on bluefin tuna as their primary target.[4] Wyrwas traveled globally to harvest the best bluefin cells for experimentation, and in 2017, Finless Foods achieved a pivotal milestone: creating the first fish meat grown outside a living fish to ever be consumed by a person.[4]
The company commenced laboratory operations in March 2017 from its Emeryville, California headquarters.[2] Early momentum was significant—by 2021, both founders earned spots on Forbes' 30 Under 30 for social impact, and the company had secured $3.5 million in seed funding.[4] In May 2022, Finless Foods launched a plant-based "tuna analogue" product with national availability, followed by cultivated nigiri products that garnered positive reviews for flavor and texture.[2]
# Core Differentiators
# Role in the Broader Tech Landscape
Finless Foods operates within the cellular agriculture movement, a subset of alternative protein technology that leverages biotechnology to produce real animal products without raising or slaughtering animals.[3] The company rides the convergence of three major trends: climate consciousness, food security concerns, and advances in biotech manufacturing.
The timing is critical. Global seafood demand continues rising while wild fish stocks deplete at accelerating rates, creating both environmental urgency and market opportunity.[5] Finless Foods' focus on bluefin tuna—a luxury protein commanding premium prices—positions the company to achieve profitability faster than competitors targeting commodity proteins. This contrasts with cultured meat companies like Believer Meats, which target broader beef and poultry markets with lower price points.[1]
Within the food-tech ecosystem, Finless Foods influences investor appetite for cellular agriculture by demonstrating technical feasibility and cost reduction potential. The company's success or challenges will shape capital allocation across alternative seafood ventures and inform regulatory frameworks for cultured food products globally.
# Quick Take & Future Outlook
Finless Foods stands at an inflection point. The company has moved beyond proof-of-concept into commercialization, with plant-based products already in market and cultivated products approaching regulatory approval.[2] The critical challenge ahead is scaling production while maintaining cost competitiveness—achieving true price parity with wild-caught bluefin tuna remains essential for mainstream adoption.
Market forces favor Finless Foods: regulatory bodies are becoming more receptive to cultured seafood, consumer demand for sustainable proteins continues accelerating, and the company's early-mover advantage in bluefin tuna cultivation is defensible through patents and proprietary cell lines. However, competition from both traditional aquaculture improvements and other cellular agriculture startups will intensify.
The company's trajectory will likely depend on whether it can transition from venture-backed startup to profitable food manufacturer—a transition that requires not just technical innovation but operational excellence in food production, supply chain management, and retail distribution. If successful, Finless Foods could establish the template for how biotechnology companies scale into mainstream food production, fundamentally reshaping how humanity sources premium seafood.
Finless Foods has raised $88.0M across 4 funding rounds. Most recently, it raised $34.0M Series B in March 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Mar 1, 2022 | $34.0M Series B | 500 Global, Alkeon Capital, At One Ventures, BoxOne Ventures, Buckley Ventures, Matt Ocko, Earl Grey Capital, Endeavor Venture Funds, FirstHand Alliance, Goat Capital, Graph Ventures, GRID EXPONENTIAL, GSV Ventures, LAUNCH, Lightspeed Venture Partners, Maven Ventures, Pario Ventures, Runa Capital, Shaan's All Access Fund, SOSV, Aaron King, Aaron Rankin (Sprout Social), Adam Michalski, Bill Tai, Chris Fanini, Daniel Kan, Emmett Shear, Immad Akhund, Jason Hunt, Jay Jamison, Kyle Vogt, Mikhail Seregine, Oleg Rogynskyy, Ted Serbinski, Vikas Gupta, Viral Bajaria, Vishal Rao | |
| Sep 1, 2021 | $40.0M Series B | Jenny Fielding, Scott Hartley, TEN13, VU Venture Partners | |
| Aug 1, 2020 | $10.0M Series A | GRID EXPONENTIAL, SOSV | |
| Jun 1, 2018 | $4.0M Seed | 8090 Industries, Alumni Ventures, B Capital Group, Flying Fish Partners, HOF Capital, Ligature, Operator Collective, Path Ventures, Social Capital, Tiger Global Management, Unlock Venture Partners |